Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 2.12
0.952 %
$ 418 M
Market Cap
-3.16
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
82.76%
EBIT
Estimate
--62.04%
Net Income
Estimate
38.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Esperion Therapeutics, Inc.
ESPR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ESPR
EBIT FORECAST
EBIT Forecast Chart ESPR
NET INCOME FORECAST
Net Income Chart ESPR